Clinical Trials
3 trialsNCT06084884 2026-05-22
ATHENA
AstraZeneca
Phase 1/2 Active not recruiting
NCT06849921 2025-02-27
Precise Design of Cell Therapy for Relapsed and Refractory Hematological Tumors
Ruijin Hospital
Phase NA Active not recruiting
NCT02193503 2023-09-28
MVX-ONCO-1 in Patients With Solid Tumor
Maxivax SA
Phase 1 Active not recruiting